Predictors of non-referral of patients with cystic fibrosisfor lung transplant evaluation in the United States

Journal of Cystic Fibrosis

Volumn 15, Issue 2, 2016, Pages 196-203

  Ramos, Kathleen J ^a   Quon, Bradley S ^b   Psoter, Kevin J ^c   Lease, Erika D ^a   Mayer Hamblett, Nicole ^d,e,f   Aitken, Moira L ^a   Goss, Christopher H ^a,d,f  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cystic fibrosis; Lung transplantation; Referral

Indexed keywords

OXYGEN;

ADULT; ARTICLE; BURKHOLDERIA CEPACIA COMPLEX; CYSTIC FIBROSIS; EDUCATION; FEMALE; FORCED EXPIRATORY VOLUME; HIGH SCHOOL GRADUATE; HUMAN; INSURANCE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAID; OXYGEN SUPPLY; PREDICTOR VARIABLE; REGISTER; RETROSPECTIVE STUDY; SPUTUM CULTURE; UNITED STATES; DISEASE COURSE; FOLLOW UP; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; PATIENT REFERRAL; PATIENT SELECTION; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

ADULT; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG TRANSPLANTATION; MALE; PATIENT SELECTION; REFERRAL AND CONSULTATION; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; UNITED STATES;

EID: 84954290671     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2015.11.005     Document Type: Article

References (16)

1. Cystic Fibrosis Foundation Patient Registry 2012 annual data report 2013, [Bethesda, Maryland].
2. O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet 2009, 373:1891-1904.
3. Stoltz D.A., Meyerholz D.K., Welsh M.J. Origins of cystic fibrosis lung disease. N Engl J Med 2015, 372:351-362.
4. Yusen R.D., Edwards L.B., Kucheryavaya A.Y., Benden C., Dipchand A.I., Dobbels F., et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report-2014; focus theme: retransplantation. J Heart Lung Transplant: The Official Publication of the International Society for Heart Transplantation 2014, 33:1009-1024.
5. Orens J.B., Estenne M., Arcasoy S., Conte J.V., Corris P., Egan J.J., et al. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant: The Official Publication of the International Society for Heart Transplantation 2006, 25:745-755.
6. Weill D., Benden C., Corris P.A., Dark J.H., Davis R.D., Keshavjee S., et al. A consensus document for the selection of lung transplant candidates: 2014-an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant: the Official Publication of the International Society for Heart Transplantation 2015, 34:1-15.
7. Mayer-Hamblett N., Rosenfeld M., Emerson J., Goss C.H., Aitken M.L. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med 2002, 166:1550-1555.
8. Kerem E., Reisman J., Corey M., Canny G.J., Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992, 326:1187-1191.
9. Liou T.G., Adler F.R., Cahill B.C., FitzSimmons S.C., Huang D., Hibbs J.R., et al. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA 2001, 286:2683-2689.
10. Maurer J.R., Frost A.E., Estenne M., Higenbottam T., Glanville A.R. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. J Heart Lung Transplant: The Official Publication of the International Society for Heart Transplantation 1998, 17:703-709.
11. Quon B.S., Psoter K., Mayer-Hamblett N., Aitken M.L., Li C.I., Goss C.H. Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic status. Am J Respir Crit Care Med 2012, 186:1008-1013.
12. Schechter M.S., Shelton B.J., Margolis P.A., Fitzsimmons S.C. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 2001, 163:1331-1337.
13. Chaparro C., Maurer J., Gutierrez C., Krajden M., Chan C., Winton T., et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 2001, 163:43-48.
14. Fauroux B., Hart N., Belfar S., Boule M., Tillous-Borde I., Bonnet D., et al. Burkholderia cepacia is associated with pulmonary hypertension and increased mortality among cystic fibrosis patients. J Clin Microbiol 2004, 42:5537-5541.
15. Stephenson AL, Sykes J, Berthiaume Y, Singer LG, Aaron SD, Whitmore GA, Stanojevic S. Clinical and Demographic Factors Associated with Post-lung Transplantation Survival in Individuals with Cystic Fibrosis. The Journal of Heart and Lung Transplantation.
16. Aris R.M., Routh J.C., LiPuma J.J., Heath D.G., Gilligan P.H. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001, 164:2102-2106.